WO1993025232A9 - Utilisation de lait hyperimmun pour augmenter la longevite - Google Patents
Utilisation de lait hyperimmun pour augmenter la longeviteInfo
- Publication number
- WO1993025232A9 WO1993025232A9 PCT/US1993/005199 US9305199W WO9325232A9 WO 1993025232 A9 WO1993025232 A9 WO 1993025232A9 US 9305199 W US9305199 W US 9305199W WO 9325232 A9 WO9325232 A9 WO 9325232A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- milk
- animal
- atcc
- human
- hyperimmune
- Prior art date
Links
- 210000004080 Milk Anatomy 0.000 title claims abstract description 233
- 235000013336 milk Nutrition 0.000 title claims abstract description 233
- 239000008267 milk Substances 0.000 title claims abstract description 233
- 230000000521 hyperimmunizing Effects 0.000 title claims abstract description 145
- 230000032683 aging Effects 0.000 claims abstract description 47
- 230000037396 body weight Effects 0.000 claims description 26
- 239000000843 powder Substances 0.000 claims description 21
- 229960005486 vaccines Drugs 0.000 claims description 18
- 230000001965 increased Effects 0.000 claims description 17
- 235000020183 skimmed milk Nutrition 0.000 claims description 17
- 230000000979 retarding Effects 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 abstract description 77
- 241001465754 Metazoa Species 0.000 abstract description 48
- 230000000968 intestinal Effects 0.000 abstract description 36
- 239000000427 antigen Substances 0.000 abstract description 34
- 102000038129 antigens Human genes 0.000 abstract description 34
- 108091007172 antigens Proteins 0.000 abstract description 34
- 230000001580 bacterial Effects 0.000 abstract description 26
- 230000003247 decreasing Effects 0.000 abstract description 18
- 230000001934 delay Effects 0.000 abstract description 3
- 210000004027 cells Anatomy 0.000 description 104
- 102000004965 antibodies Human genes 0.000 description 35
- 108090001123 antibodies Proteins 0.000 description 35
- 241000283690 Bos taurus Species 0.000 description 28
- 210000000952 Spleen Anatomy 0.000 description 26
- 230000035492 administration Effects 0.000 description 26
- 235000005911 diet Nutrition 0.000 description 26
- 230000000694 effects Effects 0.000 description 25
- 230000037213 diet Effects 0.000 description 23
- 210000002966 Serum Anatomy 0.000 description 22
- 230000001900 immune effect Effects 0.000 description 22
- 241000700159 Rattus Species 0.000 description 19
- 239000000203 mixture Substances 0.000 description 19
- 230000003053 immunization Effects 0.000 description 18
- 238000002649 immunization Methods 0.000 description 18
- 210000004837 Gut-associated lymphoid tissue Anatomy 0.000 description 15
- 210000001035 Gastrointestinal Tract Anatomy 0.000 description 14
- 206010061598 Immunodeficiency Diseases 0.000 description 13
- 102000004851 Immunoglobulin G Human genes 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- 201000009910 diseases by infectious agent Diseases 0.000 description 12
- 230000029578 entry into host Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 108090000206 Autoantibodies Proteins 0.000 description 11
- 102000003852 Autoantibodies Human genes 0.000 description 11
- 230000001461 cytolytic Effects 0.000 description 11
- 230000036737 immune function Effects 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000004166 bioassay Methods 0.000 description 10
- 239000002609 media Substances 0.000 description 10
- 239000003226 mitogen Substances 0.000 description 10
- 230000002633 protecting Effects 0.000 description 10
- 230000002062 proliferating Effects 0.000 description 9
- 241000588921 Enterobacteriaceae Species 0.000 description 8
- 210000001744 T-Lymphocytes Anatomy 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 230000001681 protective Effects 0.000 description 8
- 230000004043 responsiveness Effects 0.000 description 8
- 230000000638 stimulation Effects 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 7
- 210000004698 Lymphocytes Anatomy 0.000 description 7
- 241000283898 Ovis Species 0.000 description 7
- 230000002354 daily Effects 0.000 description 7
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 239000011859 microparticle Substances 0.000 description 7
- 241000282898 Sus scrofa Species 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- 235000013365 dairy product Nutrition 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108010045030 monoclonal antibodies Proteins 0.000 description 6
- 102000005614 monoclonal antibodies Human genes 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000001629 suppression Effects 0.000 description 6
- 241000282817 Bovidae Species 0.000 description 5
- 210000003743 Erythrocytes Anatomy 0.000 description 5
- 210000001165 Lymph Nodes Anatomy 0.000 description 5
- 210000003563 Lymphoid Tissue Anatomy 0.000 description 5
- 230000003172 anti-dna Effects 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 244000005709 gut microbiome Species 0.000 description 5
- 230000002297 mitogenic Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 230000028016 temperature homeostasis Effects 0.000 description 5
- 206010000565 Acquired immunodeficiency syndrome Diseases 0.000 description 4
- 210000004534 Cecum Anatomy 0.000 description 4
- IQFYYKKMVGJFEH-XLPZGREQSA-N DEOXYTHYMIDINE Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- 238000000692 Student's t-test Methods 0.000 description 4
- 108091008153 T cell receptors Proteins 0.000 description 4
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 4
- 210000001541 Thymus Gland Anatomy 0.000 description 4
- 230000000961 alloantigen Effects 0.000 description 4
- 230000003115 biocidal Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 239000003701 inert diluent Substances 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000006011 modification reaction Methods 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000002992 thymic Effects 0.000 description 4
- 210000004881 tumor cells Anatomy 0.000 description 4
- 206010003816 Autoimmune disease Diseases 0.000 description 3
- 206010060945 Bacterial infection Diseases 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 229920000903 Polyhydroxyalkanoate Polymers 0.000 description 3
- 102000007544 Whey Proteins Human genes 0.000 description 3
- 108010046377 Whey Proteins Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000000735 allogeneic Effects 0.000 description 3
- 230000003915 cell function Effects 0.000 description 3
- 230000000378 dietary Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drugs Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000002865 immune cell Anatomy 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 210000000056 organs Anatomy 0.000 description 3
- 238000009928 pasteurization Methods 0.000 description 3
- 230000001717 pathogenic Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000004083 survival Effects 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 210000001519 tissues Anatomy 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamins Natural products 0.000 description 3
- 235000021119 whey protein Nutrition 0.000 description 3
- 235000008939 whole milk Nutrition 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000606125 Bacteroides Species 0.000 description 2
- 210000004369 Blood Anatomy 0.000 description 2
- 241000589874 Campylobacter fetus Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 241000193171 Clostridium butyricum Species 0.000 description 2
- 241000193167 Clostridium cochlearium Species 0.000 description 2
- 241000193468 Clostridium perfringens Species 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 241000605909 Fusobacterium Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Natural products OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 210000000987 Immune System Anatomy 0.000 description 2
- 240000001929 Lactobacillus brevis Species 0.000 description 2
- 206010024324 Leukaemias Diseases 0.000 description 2
- 210000000265 Leukocytes Anatomy 0.000 description 2
- 210000002540 Macrophages Anatomy 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 240000005158 Phaseolus vulgaris Species 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 241000018778 Potamocarcinus magnus Species 0.000 description 2
- 210000003324 RBC Anatomy 0.000 description 2
- 241000607356 Salmonella enterica subsp. arizonae Species 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 229940104230 Thymidine Drugs 0.000 description 2
- 229940029983 VITAMINS Drugs 0.000 description 2
- 241000607598 Vibrio Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000000844 anti-bacterial Effects 0.000 description 2
- 229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 description 2
- 238000006065 biodegradation reaction Methods 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- -1 coline Natural products 0.000 description 2
- 230000001010 compromised Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 230000001926 lymphatic Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 229960000060 monoclonal antibodies Drugs 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000003389 potentiating Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 230000001235 sensitizing Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007909 solid dosage form Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 1
- 101710026914 AAG Proteins 0.000 description 1
- 241001659321 ANME-2 cluster Species 0.000 description 1
- 241001430193 Absiella dolichum Species 0.000 description 1
- 241001531194 Absiella tortuosum Species 0.000 description 1
- 241000590020 Achromobacter Species 0.000 description 1
- 241001673062 Achromobacter xylosoxidans Species 0.000 description 1
- 241000604450 Acidaminococcus fermentans Species 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 241000186045 Actinomyces naeslundii Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 238000006261 Adler reaction Methods 0.000 description 1
- 241000193792 Aerococcus viridans Species 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 241000588813 Alcaligenes faecalis Species 0.000 description 1
- 241001135230 Alistipes putredinis Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241001464890 Anaerococcus prevotii Species 0.000 description 1
- 241000193457 Anaerocolumna aminovalerica Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 241000193815 Atopobium minutum Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010016924 Bacterial Antibodies Proteins 0.000 description 1
- 206010070545 Bacterial translocation Diseases 0.000 description 1
- 241000606126 Bacteroidaceae Species 0.000 description 1
- 241001135322 Bacteroides eggerthii Species 0.000 description 1
- 241000606124 Bacteroides fragilis Species 0.000 description 1
- 241001135228 Bacteroides ovatus Species 0.000 description 1
- 241000606123 Bacteroides thetaiotaomicron Species 0.000 description 1
- 241000606219 Bacteroides uniformis Species 0.000 description 1
- 241000606215 Bacteroides vulgatus Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 241000186014 Bifidobacterium angulatum Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000186011 Bifidobacterium catenulatum Species 0.000 description 1
- 241000186020 Bifidobacterium dentium Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 241000186148 Bifidobacterium pseudolongum Species 0.000 description 1
- 241000123777 Blautia obeum Species 0.000 description 1
- 241001464894 Blautia producta Species 0.000 description 1
- 241000283725 Bos Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 241000605900 Butyrivibrio fibrisolvens Species 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000606177 Campylobacter ureolyticus Species 0.000 description 1
- 241000245894 Carabus irregularis Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000499489 Castor canadensis Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 240000001817 Cereus hexagonus Species 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 241000588919 Citrobacter freundii Species 0.000 description 1
- 241000588917 Citrobacter koseri Species 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- 241000193401 Clostridium acetobutylicum Species 0.000 description 1
- 241000186522 Clostridium aurantibutyricum Species 0.000 description 1
- 241000186542 Clostridium baratii Species 0.000 description 1
- 241000193455 Clostridium cadaveris Species 0.000 description 1
- 241000186562 Clostridium carnis Species 0.000 description 1
- 241000206044 Clostridium chauvoei Species 0.000 description 1
- 241001509499 Clostridium felsineum Species 0.000 description 1
- 241001656807 Clostridium haemolyticum Species 0.000 description 1
- 241000186565 Clostridium malenominatum Species 0.000 description 1
- 241001531199 Clostridium moniliforme Species 0.000 description 1
- 241000186580 Clostridium oceanicum Species 0.000 description 1
- 241001147791 Clostridium paraputrificum Species 0.000 description 1
- 241000193469 Clostridium pasteurianum Species 0.000 description 1
- 241000408944 Clostridium putrefaciens Species 0.000 description 1
- 241000193466 Clostridium septicum Species 0.000 description 1
- 241000186524 Clostridium subterminale Species 0.000 description 1
- 241000192020 Clostridium ventriculi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241001262170 Collinsella aerofaciens Species 0.000 description 1
- 241001464948 Coprococcus Species 0.000 description 1
- 241000220677 Coprococcus catus Species 0.000 description 1
- 241000949098 Coprococcus comes Species 0.000 description 1
- 241001464949 Coprococcus eutactus Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 241001464974 Cutibacterium avidum Species 0.000 description 1
- 241001464975 Cutibacterium granulosum Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000186540 Desulfosporosinus orientis Species 0.000 description 1
- 241000186541 Desulfotomaculum Species 0.000 description 1
- 241000186538 Desulfotomaculum nigrificans Species 0.000 description 1
- 241000186539 Desulfotomaculum ruminis Species 0.000 description 1
- VHJLVAABSRFDPM-ZXZARUISSA-N Dithioerythritol Chemical compound SC[C@H](O)[C@H](O)CS VHJLVAABSRFDPM-ZXZARUISSA-N 0.000 description 1
- 241001531200 Dorea formicigenerans Species 0.000 description 1
- 241000607473 Edwardsiella <enterobacteria> Species 0.000 description 1
- 241000345369 Edwardsiella hoshinae Species 0.000 description 1
- 241000607471 Edwardsiella tarda Species 0.000 description 1
- 241001657508 Eggerthella lenta Species 0.000 description 1
- 241001430190 Eggerthia catenaformis Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 229940088598 Enzyme Drugs 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000193456 Eubacterium barkeri Species 0.000 description 1
- 241000186398 Eubacterium limosum Species 0.000 description 1
- 241001646703 Eubacterium multiforme Species 0.000 description 1
- 241001646696 Eubacterium nitritogenes Species 0.000 description 1
- 241001531190 Eubacterium ramulus Species 0.000 description 1
- 241001531192 Eubacterium ventriosum Species 0.000 description 1
- 244000307267 Exacum tenue Species 0.000 description 1
- 241001531274 Faecalicatena contorta Species 0.000 description 1
- 241000186589 Faecalicatena orotica Species 0.000 description 1
- 241001531275 Faecalitalea cylindroides Species 0.000 description 1
- 108010087819 Fc receptors Proteins 0.000 description 1
- 102000009109 Fc receptors Human genes 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000605896 Fibrobacter succinogenes Species 0.000 description 1
- 241001134569 Flavonifractor plautii Species 0.000 description 1
- 241001137350 Fratercula Species 0.000 description 1
- 241000605908 Fusobacterium gonidiaformans Species 0.000 description 1
- 241001303074 Fusobacterium naviforme Species 0.000 description 1
- 241000605974 Fusobacterium necrogenes Species 0.000 description 1
- 241000605952 Fusobacterium necrophorum Species 0.000 description 1
- 241000605986 Fusobacterium nucleatum Species 0.000 description 1
- 241000605978 Fusobacterium russii Species 0.000 description 1
- 241000605975 Fusobacterium varium Species 0.000 description 1
- 210000000224 Granular leucocyte Anatomy 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000588729 Hafnia alvei Species 0.000 description 1
- 241000186568 Hathewaya limosa Species 0.000 description 1
- 241000186399 Holdemanella biformis Species 0.000 description 1
- 208000006572 Human Influenza Diseases 0.000 description 1
- 208000002370 Immune Complex Disease Diseases 0.000 description 1
- 102000018358 Immunoglobulins Human genes 0.000 description 1
- 108060003951 Immunoglobulins Proteins 0.000 description 1
- 206010022000 Influenza Diseases 0.000 description 1
- 210000004347 Intestinal Mucosa Anatomy 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 229940057428 LACTOPEROXIDASE Drugs 0.000 description 1
- 101700021338 LEC Proteins 0.000 description 1
- 101700048515 LEC1 Proteins 0.000 description 1
- 101700046135 LEC2 Proteins 0.000 description 1
- 101700077545 LECC Proteins 0.000 description 1
- 101700028499 LECG Proteins 0.000 description 1
- 101700028593 LECH Proteins 0.000 description 1
- 101700063913 LECT Proteins 0.000 description 1
- 241001134638 Lachnospira Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 241000186679 Lactobacillus buchneri Species 0.000 description 1
- 240000004403 Lactobacillus casei Species 0.000 description 1
- 241000218492 Lactobacillus crispatus Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 241001134654 Lactobacillus leichmannii Species 0.000 description 1
- 241001438705 Lactobacillus rogosae Species 0.000 description 1
- 241000186870 Lactobacillus ruminis Species 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 102000028880 Lactoperoxidase Human genes 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 241001453171 Leptotrichia Species 0.000 description 1
- 241000123728 Leptotrichia buccalis Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000006971 Mastocytoma Diseases 0.000 description 1
- 241000043361 Megamonas hypermegale Species 0.000 description 1
- 235000011779 Menyanthes trifoliata Nutrition 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000509622 Mitsuokella multacida Species 0.000 description 1
- 241000588621 Moraxella Species 0.000 description 1
- 241000588629 Moraxella lacunata Species 0.000 description 1
- 241000588630 Moraxella nonliquefaciens Species 0.000 description 1
- 241001478294 Moraxella osloensis Species 0.000 description 1
- 241000588772 Morganella morganii Species 0.000 description 1
- 210000004400 Mucous Membrane Anatomy 0.000 description 1
- 240000007639 Nepenthes mirabilis Species 0.000 description 1
- 210000000440 Neutrophils Anatomy 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 101710034340 Os04g0173800 Proteins 0.000 description 1
- 241000266823 Oscillospira guilliermondii Species 0.000 description 1
- 241000006864 Palythoa variabilis Species 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 241000588912 Pantoea agglomerans Species 0.000 description 1
- 241000606210 Parabacteroides distasonis Species 0.000 description 1
- 241000193157 Paraclostridium bifermentans Species 0.000 description 1
- 241001384595 Paratachys micros Species 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000036267 Penicillium jensenii Species 0.000 description 1
- 241001112694 Peptococcaceae Species 0.000 description 1
- 241000206591 Peptococcus Species 0.000 description 1
- 241000192013 Peptoniphilus asaccharolyticus Species 0.000 description 1
- 241000191992 Peptostreptococcus Species 0.000 description 1
- 241000192035 Peptostreptococcus anaerobius Species 0.000 description 1
- 210000001986 Peyer's Patches Anatomy 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 241000294807 Phaseolus parvulus Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 241000606999 Plesiomonas shigelloides Species 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 241001135211 Porphyromonas asaccharolytica Species 0.000 description 1
- 241001135223 Prevotella melaninogenica Species 0.000 description 1
- 241001135261 Prevotella oralis Species 0.000 description 1
- 241000605860 Prevotella ruminicola Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588768 Providencia Species 0.000 description 1
- 241000576783 Providencia alcalifaciens Species 0.000 description 1
- 241000588777 Providencia rettgeri Species 0.000 description 1
- 241000588778 Providencia stuartii Species 0.000 description 1
- 241001528479 Pseudoflavonifractor capillosus Species 0.000 description 1
- 241000186336 Pseudopropionibacterium propionicum Species 0.000 description 1
- 241000184246 Pseudoramibacter alactolyticus Species 0.000 description 1
- 241001148186 Psychrobacter phenylpyruvicus Species 0.000 description 1
- 239000007759 RPMI Media 1640 Substances 0.000 description 1
- 229940100618 Rectal Suppository Drugs 0.000 description 1
- 206010067470 Rotavirus infection Diseases 0.000 description 1
- 241000192031 Ruminococcus Species 0.000 description 1
- 241000192029 Ruminococcus albus Species 0.000 description 1
- 241000123753 Ruminococcus bromii Species 0.000 description 1
- 241000192026 Ruminococcus flavefaciens Species 0.000 description 1
- 241000202356 Ruminococcus lactaris Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000607132 Salmonella enterica subsp. enterica serovar Gallinarum Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 206010039447 Salmonellosis Diseases 0.000 description 1
- 241000192023 Sarcina Species 0.000 description 1
- 241000605036 Selenomonas Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000607717 Serratia liquefaciens Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241000881771 Serratia rubidaea Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000607766 Shigella boydii Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010040550 Shigella infection Diseases 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241001648293 Succinivibrio dextrinosolvens Species 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 241001509489 Terrisporobacter glycolicus Species 0.000 description 1
- 241000167944 Tissierella praeacuta Species 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 241001147795 Tyzzerella nexilis Species 0.000 description 1
- 229940099259 Vaseline Drugs 0.000 description 1
- 241001148135 Veillonella parvula Species 0.000 description 1
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 1
- 241000607493 Vibrionaceae Species 0.000 description 1
- 229940088594 Vitamin Drugs 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 241000607477 Yersinia pseudotuberculosis Species 0.000 description 1
- 241001147786 [Clostridium] cellobioparum Species 0.000 description 1
- 241000186561 [Clostridium] clostridioforme Species 0.000 description 1
- 241001147717 [Clostridium] sphenoides Species 0.000 description 1
- 241000186586 [Clostridium] sporosphaeroides Species 0.000 description 1
- 241001646708 [Eubacterium] budayi Species 0.000 description 1
- 241001147774 [Eubacterium] cellulosolvens Species 0.000 description 1
- 241001531271 [Eubacterium] combesii Species 0.000 description 1
- 241001531273 [Eubacterium] eligens Species 0.000 description 1
- 241001531197 [Eubacterium] hallii Species 0.000 description 1
- 241001531188 [Eubacterium] rectale Species 0.000 description 1
- 241001531189 [Eubacterium] siraeum Species 0.000 description 1
- 241001464870 [Ruminococcus] torques Species 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000240 adjuvant Effects 0.000 description 1
- 230000001058 adult Effects 0.000 description 1
- 230000004523 agglutinating Effects 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000001668 ameliorated Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000890 antigenic Effects 0.000 description 1
- 230000003190 augmentative Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001419 dependent Effects 0.000 description 1
- 230000001809 detectable Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 210000002919 epithelial cells Anatomy 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N ethanolamine Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000002318 immunoblotting Methods 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010406 interfacial reaction Methods 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101700036391 lecA Proteins 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000002934 lysing Effects 0.000 description 1
- 230000002101 lytic Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 201000006512 mast cell neoplasm Diseases 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 230000003287 optical Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 244000052769 pathogens Species 0.000 description 1
- 230000000737 periodic Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 108010086652 phytohemagglutinin-P Proteins 0.000 description 1
- 229920000747 poly(lactic acid) polymer Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000006215 rectal suppository Substances 0.000 description 1
- 230000000241 respiratory Effects 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Abstract
La présente invention concerne l'utilisation de lait hyperimmun produit par des animaux laitiers hyperimmunisés avec des antigènes bactériens, y compris des bactéries intestinales. L'administration dudit lait hyperimmun à des animaux retarde efficacement le vieillissement physiologique, augmente la longévité, retarde le démarrage du vieillissement physiologique, et rétablit la capacité fonctionnelle physiologique chez des animaux physiologiquement ou chronologiquement agés. Plus spécifiquement, ledit lait hyperimmun est administré à des animaux, en quantité suffisante pour retarder efficacement le vieillissement physiologique, augmenter la longévité, retarder le démarrage du vieillissement physiologique, ou bien rétablir une capacité fonctionnelle physiologique diminuée chez des animaux physiologiquement ou chronologiquement agés.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6501545A JPH07507798A (ja) | 1992-06-16 | 1993-05-26 | 寿命延長のための高度免疫乳の使用 |
| EP93915175A EP0646014A4 (fr) | 1992-06-16 | 1993-05-26 | Utilisation de lait hyperimmun pour augmenter la longevite. |
| AU45259/93A AU680617B2 (en) | 1992-06-16 | 1993-05-26 | The use of hyperimmune milk to increase longevity |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89951992A | 1992-06-16 | 1992-06-16 | |
| US07/899,519 | 1992-06-16 | ||
| US5364993A | 1993-04-28 | 1993-04-28 | |
| US08/053,649 | 1993-04-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1993025232A1 WO1993025232A1 (fr) | 1993-12-23 |
| WO1993025232A9 true WO1993025232A9 (fr) | 1994-05-26 |
Family
ID=26732096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1993/005199 WO1993025232A1 (fr) | 1992-06-16 | 1993-05-26 | Utilisation de lait hyperimmun pour augmenter la longevite |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0646014A4 (fr) |
| JP (1) | JPH07507798A (fr) |
| AU (1) | AU680617B2 (fr) |
| CA (1) | CA2136641A1 (fr) |
| IL (1) | IL105912A (fr) |
| NZ (3) | NZ299579A (fr) |
| WO (1) | WO1993025232A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6056978A (en) * | 1992-06-16 | 2000-05-02 | Stolle Milk Biologics, Inc. | Use of hyperimmune milk to prevent suppression of T-lymphocyte production |
| AU2002367161A1 (en) * | 2001-12-24 | 2003-07-15 | Fonterra Co-Operative Group Limited | Immunoglobulin composition |
| EP3314007B1 (fr) | 2015-06-25 | 2024-01-24 | Native Microbials, Inc. | Procédés, appareils et systèmes pour analyser des souches de micro-organismes de communautés hétérogènes complexes, prédire et identifier des relations et des interactions fonctionnelles correspondantes et sélectionner et synthétiser des ensembles microbiens basés sur ceux-ci |
| US10851399B2 (en) | 2015-06-25 | 2020-12-01 | Native Microbials, Inc. | Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
| US9938558B2 (en) | 2015-06-25 | 2018-04-10 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
| RU2018128578A (ru) | 2016-01-07 | 2020-02-10 | Аскус Байосайенсиз, Инк. | Способы улучшения продукции молока путем введения микробных консорциумов |
| US11891647B2 (en) | 2016-12-28 | 2024-02-06 | Native Microbials, Inc. | Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon |
| US11044924B2 (en) | 2017-04-28 | 2021-06-29 | Native Microbials, Inc. | Methods for supporting grain intensive and or energy intensive diets in ruminants by administration of a synthetic bioensemble of microbes or purified strains therefor |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE16349T1 (de) * | 1981-04-28 | 1985-11-15 | Stolle Res & Dev | Verfahren zur herstellung einer entzuendungshemmenden rindermilch. |
| US4879110A (en) * | 1983-10-27 | 1989-11-07 | Stolle Research And Development Corporation | Antihypertensive hyperimmune milk, production, composition, and use |
| US4636384A (en) * | 1982-06-03 | 1987-01-13 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
| JPS6099120A (ja) * | 1983-11-04 | 1985-06-03 | Asahi Glass Co Ltd | ポリイソシアヌレ−ト系フオ−ムの製造方法 |
| US4814359A (en) * | 1987-12-30 | 1989-03-21 | Union Carbide Corporation | Process for producing flexible polyurethane foam using hexahydro-S-triazine catalysts |
| FI892006A (fi) * | 1988-04-29 | 1989-10-30 | Phil Gold | Lactalbumin saosom tillaeggsaemne i mat. |
| JPH0699533B2 (ja) * | 1988-11-24 | 1994-12-07 | アキレス株式会社 | ウレタン変性ポリイソシアヌレートフォームの製造方法 |
| JPH04359036A (ja) * | 1991-06-03 | 1992-12-11 | Bridgestone Corp | 硬質ポリウレタンフォ−ムの製造方法 |
-
1993
- 1993-05-26 WO PCT/US1993/005199 patent/WO1993025232A1/fr not_active Application Discontinuation
- 1993-05-26 AU AU45259/93A patent/AU680617B2/en not_active Ceased
- 1993-05-26 NZ NZ299579A patent/NZ299579A/xx unknown
- 1993-05-26 NZ NZ253866A patent/NZ253866A/en unknown
- 1993-05-26 NZ NZ505753A patent/NZ505753A/xx unknown
- 1993-05-26 JP JP6501545A patent/JPH07507798A/ja not_active Expired - Lifetime
- 1993-05-26 EP EP93915175A patent/EP0646014A4/fr not_active Withdrawn
- 1993-05-26 CA CA002136641A patent/CA2136641A1/fr not_active Abandoned
- 1993-06-04 IL IL10591293A patent/IL105912A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6056978A (en) | Use of hyperimmune milk to prevent suppression of T-lymphocyte production | |
| Benyacoub et al. | Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs | |
| TWI539964B (zh) | 用於廣效、未分類或混合型臨床應用之治療組合物及方法 | |
| JPH08231424A (ja) | トリの抗体を用いた哺乳動物の受動免疫化 | |
| WO1997020577A1 (fr) | Formulation therapeutique amelioree et procede correspondant | |
| CA2267421A1 (fr) | Administration orale d'anticorps a base de jaune d'oeuf de poule pour le traitement de maladies | |
| US5106618A (en) | Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product | |
| US20050226861A1 (en) | Immunogen adherence inhibitor and method of making and using same | |
| AU680617B2 (en) | The use of hyperimmune milk to increase longevity | |
| WO1993025232A9 (fr) | Utilisation de lait hyperimmun pour augmenter la longevite | |
| Cebra et al. | The role of mucosal microbiota in the development, maintenance, and pathologies of the mucosal immune system | |
| US20020009429A1 (en) | Pharmaceutical composition comprising a selected antigen and candida species antigen and methods | |
| US7560109B2 (en) | Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it | |
| Xu et al. | Bovine immune colostrum against 17 strains of diarrhea bacteria and in vitro and in vivo effects of its specific IgG | |
| KR19980081625A (ko) | 장관 출혈성 대장균에 의한 감염증의 예방제 및 치료제 | |
| US10478493B2 (en) | Method of treating protozoal gastrointestinal disorders in immunocompromised patients | |
| CA1339933C (fr) | Utilisation de produit laitier hyperimmun pour traiter les troubles gastro-intestinaux | |
| CA2438698C (fr) | Inhibiteur d'adherence d'immunogenes et sa methode d'elaboration et d'utilisation | |
| Barnard | Evaluating IgY recovery in rumen fluid and its potential role in performance and neutrophil function in lactating Holstein cows | |
| NZ531390A (en) | A method for production of a microbial adherence inhibitor for administration to host food animals to prevent the adherence of colony-forming organisms in the rumen or intestinal tract of the food animals | |
| ZA200400673B (en) | Immunogen adherence inhibitor and method of makingand using same. |